Yestino - The Signal · Foundayohttps://yestino.com/zh-CN/entities/foundayo-339775与 Foundayo 相关的全部事件zh-CNEli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up productionhttps://yestino.com/zh-CN/events/eli-lilly-ceo-tells-cnbc-one-third-of-new-glp-1-pill-patient-d5ed9dhttps://yestino.com/zh-CN/events/eli-lilly-ceo-tells-cnbc-one-third-of-new-glp-1-pill-patient-d5ed9dMon, 21 Sep 2026 17:14:29 GMTEli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space. 来源：CNBC Business